The Discounted Cash Flow (DCF) valuation of AnaptysBio Inc (ANAB) is (460.44) USD. With the latest stock price at 15.59 USD, the upside of AnaptysBio Inc based on DCF is -3053.4%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.5% - 8.0% | 7.3% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (955.43) - (307.24) | (460.44) |
| Upside | -6228.5% - -2070.8% | -3053.4% |